These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24108425)

  • 1. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
    Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M
    Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.
    Frau L; Costa G; Porceddu PF; Khairnar A; Castelli MP; Ennas MG; Madeddu C; Wardas J; Morelli M
    J Neurochem; 2016 Jan; 136(1):148-62. PubMed ID: 26442661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice.
    Costa G; Spulber S; Paci E; Casu MA; Ceccatelli S; Simola N; Morelli M
    Neurotoxicology; 2021 Mar; 83():1-13. PubMed ID: 33338551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
    Frau L; Simola N; Porceddu PF; Morelli M
    Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
    Frau L; Borsini F; Wardas J; Khairnar AS; Schintu N; Morelli M
    Synapse; 2011 Mar; 65(3):181-8. PubMed ID: 20665698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
    Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.
    Rojo AI; Innamorato NG; Martín-Moreno AM; De Ceballos ML; Yamamoto M; Cuadrado A
    Glia; 2010 Apr; 58(5):588-98. PubMed ID: 19908287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.
    Costa G; Simola N; Morelli M
    Psychopharmacology (Berl); 2014 Oct; 231(20):4007-18. PubMed ID: 24687411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.
    Porceddu PF; Ishola IO; Contu L; Morelli M
    Neurotox Res; 2016 Jul; 30(1):101-9. PubMed ID: 27251371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility.
    Frau L; Simola N; Plumitallo A; Morelli M
    J Neurochem; 2013 Jan; 124(1):69-78. PubMed ID: 23083295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
    Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
    PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK/MAP Kinase Activation is Evident in Activated Microglia of the Striatum and Substantia Nigra in an Acute and Chronically-Induced Mouse Model of Parkinson's Disease.
    Sarkar S; Lu E; Raymick J; Hanig J; Gu Q
    Curr Neurovasc Res; 2018; 15(4):336-344. PubMed ID: 30468126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Carta AR; Kachroo A; Schintu N; Xu K; Schwarzschild MA; Wardas J; Morelli M
    J Neurochem; 2009 Dec; 111(6):1478-89. PubMed ID: 19817968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain.
    Khairnar A; Plumitallo A; Frau L; Schintu N; Morelli M
    Neurotox Res; 2010 May; 17(4):435-9. PubMed ID: 19882200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.